The Conference Board analysts say the question isn’t why China will slow, but why anyone thinks it won’t
Tablets remain a problem in a record-breaking quarter
From Michael Dunn's trial in Florida to discord over open-carry laws in Colorado, the debate about gun control has driven Americans to indulge their worst behavior
The company misses earnings forecasts, drops its 2015 profit goal, and regroups
Chinese millionaires are moving in—and building up—in Arcadia, Calif.
A new book surveys the best places to hide out from the digital world
The two tech giants fight over market share and patents but not over the NBA superstar
Professor Piotr Naskrecki blogged about finding and killing one of the largest type of spider in the world, triggering a barrage of hate mail
Small businesses are changing hands at the fastest pace since the recession
Kathy Callender, 67
After 12 years in business, PharmaJet may finally be able to sell its first product: a simple, needle-free injection device with a disposable syringe designed for use in third-world countries that can help prevent injury and the spread of disease. The company just received clearance from the Food & Drug Administration to use the tool for vaccines and injectable medicines. The 25-person company has not recorded any revenues to date, but plans to start selling its devices this year. So far, it has been developing the product with help from angel investors. "I want to make a difference in global world health," says Callender, a 35-year veteran of the health-care industry. "Before starting the firm, my husband and I would do medical mission work in the developing world, and it really just showed us how much need there is out there. I want to get needles out of the garbage and prevent injury to workers and patients."